← All stocks

ALX ONCOLOGY HOLDINGS INC

ALXO Net buying
CIK 0001810182 #3671 in the set updated 17 Sep 2026
Bought (12 mo)
$5.08M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$42.59K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$42.59K
7 of 7 sales
Net
+$5.03M
+$5.03M against sales at will

By person

6 insiders · 9 transactions
0.7×

Jason Lettmann holds only 0.7 times base salary in stock. $568.15K of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jason Lettmann last reported holding, valued at $1.93, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GOODMAN COREY S
Director
$5.00M (1)
+$5.00M
8,453,038
$16.31M
+60.5%
Lettmann Jason
CHIEF EXECUTIVE OFFICER
$76.89K (1)
$31.02K (2)
+$45.87K
294,379
$568.15K
+62.3%
Wong Shelly
SVP, FINANCE AND CAO
$11.57K (5)
−$11.57K
87,828
$169.51K
−12.7%
Pons Jaume
PRESIDENT & CSO
579,388
$1.12M
−2.0%
Shantharam Harish
Chief Financial Officer
75,000
$144.75K
Hemrajani Rekha
Director
33,000
$63.69K
+1,000%

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 52,743,104 to 138,276,997 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 2,201
History held since 17 Jul 2020